BAILARD, INC. - HARPOON THERAPEUTICS INC ownership

HARPOON THERAPEUTICS INC's ticker is HARP and the CUSIP is 41358P106. A total of 54 filers reported holding HARPOON THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 1.5%.

Quarter-by-quarter ownership
BAILARD, INC. ownership history of HARPOON THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$47,033
-97.1%
63,200
-46.8%
0.00%
-96.5%
Q2 2021$1,649,000
-39.7%
118,878
-9.1%
0.06%
-43.6%
Q1 2021$2,736,000
+19.4%
130,778
-5.2%
0.10%
-3.8%
Q4 2020$2,292,000
+4.6%
137,964
+6.9%
0.10%
-7.9%
Q3 2020$2,192,000
+27.6%
129,000
+24.6%
0.11%
+18.8%
Q2 2020$1,718,000
+28.5%
103,500
-10.4%
0.10%
+1.1%
Q1 2020$1,337,000115,5000.10%
Other shareholders
HARPOON THERAPEUTICS INC shareholders Q1 2020
NameSharesValueWeighting ↓
New Leaf Venture Partners, L.L.C. 3,156,699$66,038,00015.37%
MPM ASSET MANAGEMENT LLC 3,238,306$67,745,00013.09%
MPM BioImpact LLC 3,898,422$81,555,00010.25%
Aquilo Capital Management, LLC 1,554,199$32,514,0005.88%
Altium Capital Management LP 199,607$4,176,0001.16%
SECTORAL ASSET MANAGEMENT INC 631,050$13,202,0001.00%
Avidity Partners Management LP 1,408,000$29,455,0000.81%
DAFNA Capital Management LLC 126,663$2,650,0000.63%
Logos Global Management LP 300,000$6,276,0000.61%
Orbimed Advisors 2,285,704$47,817,0000.45%
View complete list of HARPOON THERAPEUTICS INC shareholders